Hereditary Diseases Dog

Diagnostic spectrum

• Achromatopsia (day blindness) (ACHM)
• Obesity
• Afibrinogenemia (AFG)
• Acatalasemia
• Acral mutilation syndrome (AMS)
• Acute respiratory distress syndrome (ARDS)
• Alaskan Husky encephalopathy (AHE)
• Alaskan Malamute polyneuropathy (AMPN)
• Alexander disease (AxD)
• Amelogenesis imperfecta / Familial enamel hypoplasia (AI/FEH)
• Bardet-Biedl syndrome (BBS)
• Brachyuria (stumpy tail)
• C3 deficiency (C3)
• Canine leucocyte adhesion deficiency (CLAD)
• Canine multi-focal retinopathy (CMR1/2/3)
• Canine multiple system degeneration (CMSD)
• Cardiomyopathy with juvenile mortality (CJM)
• Centronuclear myopathy (CNM)
• Cerebellar ataxia* (CA)
• Cerebellar degeneration and myositis complex (CDMC)
• Cerebral dysfunction (CDFS)
• Charcot-Marie-Tooth neuropathy (CMT)
• Chondrodysplasia (dwarfism)
• Chondrodysplasia (CDPA) and -dystrophia (CDDY) (IVDD risk)
• Collie eye anomaly* (CEA)
• Cone degeneration (CD)
• Congenital hypothyroidism with goiter (CHG)
• Congenital idiopathic megaesophagus (CIM)
• Congenital myasthenic syndrome (CMS)
• Craniomandibular osteopathy (CMO)
• Cystinuria
• Dandy-Walker-like malformation (DWLM)
• Degenerative myelopathy exon 1(DM exon1)
• Degenerative myelopathy exon 2 (DM exon2)
• Dental-skeletal-retinal anomaly (DSRA)
• Dermatomyositis (DMS)
• Digital hyperkeratosis (DH/HFH)
• Dilated cardiomyopathy (DCM)
• Dilated cardiomyopathy (DCM)
• Dilated cardiomyopathy DCM1 (PDK4)
• Dilated cardiomyopathy DCM2 (Titin)
• Disproportionate dwarfism
• Dry eye curly coat syndrome (CCS)
• Dyserythropoietic anaemia and myopathy (DAMS)
• Dystrophic epidermolysis bullosa (DEB)
• Ectodermal dysplasia/Skin fragility syndrome (ED/SFS)
• Inflammatory pulmonary disease (IPD)
• Inflammatory myopathy (IM)
• Epidermolytic hyperkeratosis (EHK)
• Episodic falling (EF)
• Hereditary deafness (EOAD)
• Exercise induced collapse (EIC)
• Exfoliative cutaneous lupus erythematosus (ECLE)
• Factor VII deficiency
• Congenital ichthyosis
• Familial nephropathy (FN)
• Familial Nephropathy* (FN)
• Fanconi syndrome
• Color dilution and neurological signs (CDN)
• Finnish Hound ataxia (FHA)
• Fucosidosis
• Gallbladder mucoceles (GBM)
• Glanzmann thrombasthenia (GT)
• Osteogenesis imperfecta (brittle bone disease)
• Glaucoma and goniodysgenesis (GG)
• Globoid cell leucodystrophy (Krabbe disease)
• Glycogen storage disease GSD Ia
• Glycogen storage disease GSD II (Pompe disease)
• Glycogen storage disease GSDIIIa
• GM1-Gangliosidosis (GM1)
• GM2-Gangliosidosis (GM2)
• Grey Collie syndrome (GCS) (Canine cyclic neutropenia)
• Haemophilia A (factor VIII deficiency)
• Haemophilia A (factor VIII deficiency)
• Haemophilia B (factor IX deficiency)
• Hemorrhagic diathesis (Scott syndrome)
• Hereditary ataxia (HA)
• Hereditary cataract (HSF4)
• Hereditary cataract (HSF4)*
• Hereditary nasal parakeratosis (HNPK)
• Hereditary nasal parakeratosis (HNPK)
• Hereditary neuropathy (GHN)
• Hyperuricosuria (HUU/SLC)
• Hypomyelination/Shaking puppy syndrome (SPS)
• Hypophosphatasia (HPP)
• Ichthyosis
• Ichthyosis type 2
• Ichthyosis*
• Imerslund-Gräsbeck syndrome (IGS)
• Junctional epidermolysis bullosa (JEB)
• Juvenile brain disease (JBD)
• Juvenile epilepsy (JE)
• Juvenile laryngeal paralysis & polyneuropathy (JLPP)
• Juvenile myoclonic epilepsy (JME)
• Copper storage toxicosis (CT)
• Copper storage disease - Copper toxicosis (CT)*
• L-2-hydroxyglutaric aciduria (L2HGA)
• Lafora disease (EDTA blood only)
• Lagotto storage disease (LSD)
• Laryngeal paralysis (LP)
• Laryngeal paralysis with polyneuropathy type 3 (LPPN3)
• Late onset ataxia (LOA)
• Leonberger polyneuropathy 1 (LPN1)
• Leonberger polyneuropathy 2 (LPN2)
• Lethal acrodermatitis (LAD)
• Lethal lung disease (LAMP3)
• Leukoencephalomyelopathy (LEMP)
• Leukoencephalopathy (LEP)
• Leukocyte adhesion deficiency type III (LAD3)
• Cleft lip/palate and syndactyly (CLPS)
• Lundehund syndrome (LHS)
• Macrothrombocytopenia (MTC)
• Macular corneal dystrophy (MCD)
• Malignant hyperthermia (MH)
• May-Hegglin anomaly (MHA)
• MCAD deficiency
• MDR1 gene variant (Ivermectin hypersensitivity)
• Microphthalmia (RBP4)
• Mitochondrial fission encephalopathy (MFE)
• Mucopolysaccharidosis type IIIa (MPS3a)
• Mucopolysaccharidosis type IIIb (MPS3b)
• Mucopolysaccharidosis type VI (MPS6)
• Mucopolysaccharidosis type VII (MPS7)
• Persistent Müllerian duct syndrome (PMDS)
• Muscular dystrophy (MD)
• Musladin-Lueke syndrome (MLS)
• Mycobacterium avium complex sensitivity (MAC)
• Myostatin mutation ("bully" gene)
• Myotonia congenita
• Congenital stationary night blindness (CSNB)
• Narcolepsy
• Necrotizing meningoencephalitis (NME/PDE)
• Nemalin myopathy (NM)
• Neonatal cortical cerebellar abiotrophy (NCCD)
• Neonatal encephalopathy with seizures (NEWS)
• Spinal dysraphism (NTD)
• Neuroaxonal dystrophy (NAD)
• Neuronal ceroid lipofuscinosis (NCL)
• Neuronal ceroid lipofuscinosis (NCL)
• Neuronal ceroid lipofuscinosis* (NCL)
• Renal dysplasia and hepatic fibrosis (RDHN)
• Renal cystadenocarcinoma and nodular fibrosis (RCND)
• Upper airway syndrome (UAS)
• Paroxysmal dyskinesia (PxD)
• Paroxysmal exercise-induced dyskinesia (PED)
• Phosphofructokinase deficiency (PFKD)
• Polycystic kidney disease (PKD)
• Postoperative hemorrhage (P2Y12)
• Prekallikrein deficiency (KLK)
• Primary ciliary dyskinesia (PCD)
• Primary hyperoxaluria (PH)
• Primary lens luxation (PLL)
• Primary open angle glaucoma (POAG)
• Primary open angle glaucoma and lens luxation (POAG/PLL)
• Progressive retinal atrophy (Bas-PRA1)
• Progressive retinal atrophy (BBS2-PRA)
• Progressive retinal atrophy (CNGA1-PRA)
• Progressive retinal atrophy (cord1/crd4-PRA)
• Progressive retinal atrophy (crd-PRA)
• Progressive retinal atrophy (crd1-PRA)
• Progressive retinal atrophy (crd2-PRA)
• Progressive retinal atrophy (crd3-PRA)
• Progressive retinal atrophy (dominant PRA)
• Progressive retinal atrophy (early-onset, eo-PRA)
• Progressive retinal atrophy (g-PRA)
• Progressive retinal atrophy (GR-PRA1)
• Progressive retinal atrophy (GR-PRA2)
• Progressive retinal atrophy (IFT122-PRA)
• Progressive retinal atrophy (JPH2-PRA)
• Progressive retinal atrophy (NECAP1-PRA)
• Progressive retinal atrophy (Pap-PRA1)
• Progressive retinal atrophy (PRA3)
• Progressive retinal atrophy (PRA4)
• Progressive retinal atrophy (prcd-PRA)*
• Progressive retinal atrophy (rcd1-PRA)
• Progressive retinal atrophy (rcd1a-PRA)
• Progressive retinal atrophy (rcd2-PRA)
• Progressive retinal atrophy (rcd3-PRA)
• Progressive retinal atrophy (rcd4-PRA)
• Progressive retinaatrophy (Type B1 PRA, HIVEP3)
• Progressive retinal atrophy (XL-PRA)
• Protein losing nephropathy (PLN)
• Pyruvate dehydrogenase phosphatase 1 deficiency (PDP1)
• Pyruvate kinase deficiency (PK)
• Raine syndrome
• Retinal dysplasia (OSD)
• Retinal dysplasia* (OSD)
• Robinow-like syndrome (DVL2)
• Severe combined immuno deficiency (SCID)
• Sensory neuropathy (SN)
• Shar Pei autoinflammatory disease (SPAID)
• Spinocerebellar ataxia (SCA)
• Spondylocostal dysostosis (Comma defect)
• Spongiforme leukoencephalomyelopathy* (SLEM)
• Spongy degeneration with cerebellar ataxia type 1 (SDCA1)
• Spongy degeneration with cerebellar ataxia type 2 (SDCA2)
• Stargardt disease (STGD, retinal degeneration)
• Startle disease
• Subacute necrotising encephalopathy (SNE)
• Succinic semialdehyde dehydrogenase deficiency (SSADHD)
• Thrombopathia
• Trapped neutrophil syndrome (TNS)
• van den Ende-Gupta syndrome (VDEGS)
• Ventricular arrhythmia (IVA)
• Behaviour propensity
• Vitamin D dependent rickets (VDR)
• von Willebrand disease type 1 (vWD1)
• von Willebrand disease type 2 (vWD2)
• von Willebrand disease type 3 (vWD3)
• X-chromosomal severe immuno deficiency (X-SCID)
• X-linked myopathy (XL-MTM)
• Xanthinuria type II
• CNS atrophy with cerebellar ataxia (CACA)
• Pituiary dwarfism
• Skeletal dysplasia 2 (dwarfism) (SD2)